Nadina Khamani
I.M. Sechenov First Moscow State Medical University
4 Papers
5 Citations
Nadina Khamani is an academic researcher from I.M. Sechenov First Moscow State Medical University. The author has contributed to research in topics: Internal medicine & Systematic review. The author has co-authored 1 publications. Previous affiliations of Nadina Khamani include University of Helsinki.
Chat about Author
Papers
Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology
Lauri I Lavikainen,Gordon H. Guyatt,Yung Lee,Rachel Couban,Anna Luomaranta,Ville Sallinen,Ilkka Kalliala,Ilkka Kalliala,Paul J. Karanicolas,Paul J. Karanicolas,Rufus Cartwright,Riikka Aaltonen,Kaisa Ahopelto,Karoliina Aro,Ines Beilmann-Lehtonen,Marco H. Blanker,Jovita L. Cárdenas,Samantha Craigie,Päivi J. Galambosi,Herney Andrés García-Perdomo,Fang Zhou Ge,Huda Gomaa,Linglong Huang,Matthew L Izett-Kay,Kirsi Joronen,Päivi K. Karjalainen,Nadina Khamani,Nadina Khamani,Tuomas P. Kilpeläinen,Antti Kivelä,Tapio Korhonen,Hanna Lampela,Anne K Mattila,Borna Tadayon Najafabadi,Taina Nykänen,Carolina Nystén,Sanna M Oksjoki,Sanjay Pandanaboyana,Sanjay Pandanaboyana,Negar Pourjamal,Chathura B B Ratnayake,Chathura B B Ratnayake,Aleksi R Raudasoja,Tino Singh,Riikka M. Tähtinen,Robin W.M. Vernooij,Yuting Wang,Yingqi Xiao,Yingqi Xiao,Liang Yao,Jari Haukka,Jari Haukka,Kari A.O. Tikkinen +52 more
TL;DR: In this article, the authors performed a series of systematic reviews and meta-analyses of the procedure-specific and patient risk factor stratified risk estimates in general and gynecologic surgeries.
Risk of Thrombosis and Bleeding in Gynecologic Cancer Surgery: Systematic Review and Meta-Analysis.
L. I. Lavikainen,G. Guyatt,Anna L. Luomaranta,Rufus Cartwright,Ilkka Kalliala,R. J. Couban,Riikka Aaltonen,Karoliina Aro,Jovita L. Cárdenas,P.J. Devereaux,Päivi J. Galambosi,Fang Zhou Ge,Alex L E Halme,Jari Haukka,Matthew L. Izett-Kay,K. Joronen,Päivi K. Karjalainen,Nadina Khamani,S. Oksjoki,N. Pourjamal,T. Singh,Riikka M. Tähtinen,R. Vernooij,Kari A.O. Tikkinen +23 more
TL;DR: VTE reduction with thromboprophylaxis likely outweighs increase in bleeding requiring reintervention in many gynecologic cancer procedures, and decisions depend on individual risk prediction and values and preferences regarding VTE and bleeding.
9
2022-RA-933-ESGO Risk of venous thromboembolism and major bleeding in gynaecological cancer surgery: series of systematic reviews and meta-analyses
L. I. Lavikainen,Gordon H. Guyatt,Anna Luomaranta,R. Cartwrigth,Ilkka Kalliala,Rachel Couban,Riikka Aaltonen,Karoliina Aro,Jovita L. Cárdenas,P. J. Devereaux,Päivi J. Galambosi,Fangxia Ge,Alex L E Halme,Jari Haukka,Matthew L. Izett-Kay,Kirsi Joronen,Päivi K. Karjalainen,Nadina Khamani,C. Nysten,S. Oksjoki,N. Pourjamal,T. Singh,Riikka M. Tähtinen,Robin W.M. Vernooij,Philippe D. Violette,Kari A.O. Tikkinen +25 more
- 01 Oct 2022
TL;DR: In this paper , the authors conducted a comprehensive search on Embase, MEDLINE, Web of Science, and Google Scholar to identify studies reporting symptomatic venous thromboembolism (VTE) or major bleeding (bleeding requiring reoperation, bleeding leading to transfusion, or Hb <70g/L) after gynaecological cancer surgery.
Risk of Thrombosis and Bleeding in Gynecologic Non-Cancer Surgery: Systematic Review and Meta-Analysis.
L. I. Lavikainen,G. Guyatt,Ilkka Kalliala,Rufus Cartwright,Anna L. Luomaranta,R. Vernooij,Riikka M. Tähtinen,Borna Tadayon Najafabadi,T. Singh,N. Pourjamal,S. Oksjoki,Nadina Khamani,Päivi K. Karjalainen,K. Joronen,Matthew L. Izett-Kay,Jari Haukka,Alex L E Halme,Fang Zhou Ge,Päivi J. Galambosi,P. Devereaux,Jovita L. Cárdenas,R. J. Couban,Karoliina Aro,Riikka Aaltonen,Kari A.O. Tikkinen,Kaisa Ahopelto,Yoshitaka Aoki,I. Beilmann-Lehtonen,Marco H. Blanker,Samantha Craigie,J. Elberkennou,Herney Andrés García-Perdomo,Huda Gomaa,Peter L. Gross,Sakineh Hajebrahimi,Linglong Huang,P. J. Karanicolas,Tuomas O. Kilpeläinen,A. Kivelä,Tapio Korhonen,Hanna Lampela,Yung Lee,Anne K. Mattila,Taina P. Nykänen,C. Nysten,S. Pandanaboyana,Chathura B. B. Ratnayake,Aleksi R. Raudasoja,Ville J. Sallinen,Philippe D. Violette,Yingqi Xiao,Liang Yao +51 more
TL;DR: Although most of the evidence is of low certainty, results nevertheless provide a compelling rationale for restricting pharmacologic thromboprophylaxis to a minority of patients undergoing gynecologic non-cancer procedures.